Upward trend in reported SARS-CoV-2 infections continues In the last week from 12 to 19 October 2021, 44% more people tested positive for COVID-19 compared to the week before. Reported figures increased in all regions and in all age groups.
Vaccination reduces transmission to unvaccinated household members by 63% for Delta variant Vaccination protects against COVID-19, and also reduces the risk of transmitting the virus to others.
RIVM recommends limiting number of e-cigarettes flavourings to 23 with tobacco taste only The government wishes to make e-cigarettes less attractive, in particular for young people.
4 in 5 COVID-19 patients in ICU are not vaccinated 4 in 5 COVID-19 patients in intensive care are not vaccinated against the coronavirus SARS-CoV-2.
Expected autumn increase in SARS-CoV-2 appears to have started In the past week from 5-12 October 2021, the reported number of people who tested positive for COVID-19 increased by 48% compared to the previous week. Reported figures increased in all regions and in all age groups.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
All indicators in the red In the week from 24 to 30 March, 51,866 people in the Netherlands received a positive test result for COVID-19, an increase of 13% compared to the week before that.
Home vaccination starts next week for people unable to travel Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province.